DK1230369T3 - Polypeptidhormon phosphatonin - Google Patents

Polypeptidhormon phosphatonin

Info

Publication number
DK1230369T3
DK1230369T3 DK00971403T DK00971403T DK1230369T3 DK 1230369 T3 DK1230369 T3 DK 1230369T3 DK 00971403 T DK00971403 T DK 00971403T DK 00971403 T DK00971403 T DK 00971403T DK 1230369 T3 DK1230369 T3 DK 1230369T3
Authority
DK
Denmark
Prior art keywords
polypeptide hormone
phosphatonin
hormone phosphatonin
polypeptide
hormone
Prior art date
Application number
DK00971403T
Other languages
English (en)
Inventor
Peter Rowe
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9926424.4A external-priority patent/GB9926424D0/en
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of DK1230369T3 publication Critical patent/DK1230369T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00971403T 1999-11-04 2000-10-31 Polypeptidhormon phosphatonin DK1230369T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43418599A 1999-11-04 1999-11-04
GBGB9926424.4A GB9926424D0 (en) 1999-11-08 1999-11-08 A novel polypeptide hormone phosphatonin
PCT/EP2000/010747 WO2001032878A2 (en) 1999-11-04 2000-10-31 A novel polypeptide hormone phosphatonin

Publications (1)

Publication Number Publication Date
DK1230369T3 true DK1230369T3 (da) 2008-03-31

Family

ID=26316065

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00971403T DK1230369T3 (da) 1999-11-04 2000-10-31 Polypeptidhormon phosphatonin

Country Status (13)

Country Link
EP (2) EP1870467A1 (da)
JP (3) JP4424578B2 (da)
AR (1) AR027877A1 (da)
AT (1) ATE381618T1 (da)
AU (1) AU784294B2 (da)
CA (1) CA2389644C (da)
DE (1) DE60037536T2 (da)
DK (1) DK1230369T3 (da)
ES (1) ES2296649T3 (da)
MX (1) MXPA02004416A (da)
MY (1) MY127669A (da)
PT (1) PT1230369E (da)
WO (1) WO2001032878A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790639B2 (en) * 2000-02-29 2004-09-14 Pfizer Inc. Mammalian osteoregulins
US20020102641A1 (en) * 2000-03-24 2002-08-01 Susan Schia Vi Oncogenic osteomalacia-related gene 1
JP2006502971A (ja) * 2002-05-03 2006-01-26 ミレニアム バイオロジックス インコーポレーテッド 結合組織刺激ペプチド
AU2013203943C1 (en) * 2005-09-28 2016-09-01 The Regents Of The University Of California Calcium binding peptides
AU2010210600B2 (en) 2009-02-06 2016-07-14 C3 Jian, Inc. Calcium-binding agents induce hair growth and/or nail growth
US20140107321A1 (en) * 2011-05-26 2014-04-17 Dr. Reddy's Laboratories Limited Purification of antibodies
JPWO2022014697A1 (da) * 2020-07-17 2022-01-20

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2153480A1 (en) * 1993-11-12 1995-06-01 Kenichi Matsubara Gene signature
MXPA00011272A (es) * 1998-05-18 2003-04-22 Univ London Una novedosa fosfatonina de hormona polipeptida.
GB9810681D0 (en) * 1998-05-18 1998-07-15 Royal Free Hosp School Med Hormone
EP1130094A3 (en) * 1999-07-08 2001-11-21 Helix Research Institute Primers for synthesizing full length cDNA clones and their use
US6790639B2 (en) * 2000-02-29 2004-09-14 Pfizer Inc. Mammalian osteoregulins
EP1293568A4 (en) * 2000-06-21 2005-10-26 Takeda Pharmaceutical PROTEIN AND ITS DNA

Also Published As

Publication number Publication date
PT1230369E (pt) 2008-02-15
JP2003513631A (ja) 2003-04-15
ES2296649T3 (es) 2008-05-01
MY127669A (en) 2006-12-29
EP1230369A2 (en) 2002-08-14
ATE381618T1 (de) 2008-01-15
JP4424578B2 (ja) 2010-03-03
JP2009159975A (ja) 2009-07-23
WO2001032878A3 (en) 2001-11-15
CA2389644A1 (en) 2001-05-10
DE60037536T2 (de) 2008-12-11
WO2001032878A2 (en) 2001-05-10
EP1870467A1 (en) 2007-12-26
JP2013059334A (ja) 2013-04-04
EP1230369B1 (en) 2007-12-19
AU784294B2 (en) 2006-03-02
AR027877A1 (es) 2003-04-16
DE60037536D1 (en) 2008-01-31
CA2389644C (en) 2013-02-26
MXPA02004416A (es) 2002-09-02
AU1027201A (en) 2001-05-14
JP5208021B2 (ja) 2013-06-12

Similar Documents

Publication Publication Date Title
NO2010013I2 (no) Rekombinant FSH-CTP
DE69920011D1 (de) Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff
NO982097L (no) Peptider
NO982098D0 (no) Peptider
PT926158E (pt) Hormona paratiroide cristalina
IS6040A (is) Valdekoxib efnablöndur
NO20025893L (no) Veksthormon sekretagoga
NO20020151D0 (no) Veksthormonformuleringer
GB9923177D0 (en) Novel polypeptide
DE69933647D1 (de) Rekombinante lysophosphatidsäure - phosphatase.
FR2791348B1 (fr) POLYPEPTIDE Npt2B
DK1230369T3 (da) Polypeptidhormon phosphatonin
DE50004258D1 (de) Transportvorrichtung
EP1197556A4 (en) USEFUL POLYPEPTIDE
DE50010867D1 (de) Abdeckvorrichtung
GB9923889D0 (en) Novel polypeptide
NO20013933D0 (no) Peptider
GB9924951D0 (en) Novel polypeptide
EP1179540A4 (en) NEW POLYPEPTIDES
NO20012283D0 (no) Koblede peptider
HK1045173A1 (zh) 多肽
DE50009295D1 (de) Vernetzerfreie zubereitungen
NO20021244D0 (no) Subenhet-optimaliserte fusjonsproteiner
GB9923893D0 (en) Novel polypeptide
GB9923888D0 (en) Novel polypeptide